Last reviewed: June 8, 2026

Last updated: June 8, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Compounded semaglutide and Wegovy contain the same active pharmaceutical ingredient—semaglutide—but differ in manufacturing, pricing, and insurance coverage. Understanding these distinctions helps you make an informed decision about whether a switch aligns with your weight loss goals and budget.

What Is the Difference Between Compounded and Brand-Name Semaglutide?

Compounded semaglutide is manufactured by licensed 503A compounding pharmacies under FDA oversight, while Wegovy is a brand-name product made by Novo Nordisk through FDA-approved manufacturing. Both medications deliver the same semaglutide molecule, which activates GLP-1 receptors in the brain and pancreas to reduce hunger and improve insulin sensitivity. The primary differences lie in supply chain, regulatory pathway, and cost structure rather than the medication's chemical action.

Wegovy received FDA approval for chronic weight management in 2021 and is available through traditional pharmacy channels with insurance coverage options. Compounded semaglutide from PlexusDx comes from licensed pharmacies and serves all 50 states without requiring insurance, making it accessible to uninsured and underinsured patients. Both formulations undergo quality testing, though compounding allows for flexible dosing without fixed pen increments.

Cost Comparison: Compounded Semaglutide vs. Wegovy

PlexusDx compounded semaglutide injection starts at $149 per month across all dose levels, with your dose able to increase while your price remains flat. Wegovy typically costs $900–$1,350 monthly without insurance, depending on your dose tier and retailer; with insurance, out-of-pocket costs vary widely from $50 to $500+ per month based on your plan's formulary and deductible. For patients with no insurance coverage, compounded semaglutide offers substantial savings and eliminates flat per-compound pricing increases.

HSA and FSA accounts cover both compounded semaglutide through PlexusDx and Wegovy, providing tax-advantaged spending options. If your insurance covers Wegovy at a low copay, that may offset the price advantage of compounding; however, many insurers require prior authorization, step therapy, or proof of failed treatments before approving coverage. PlexusDx eliminates these barriers, allowing you to start therapy immediately without insurance delays.

Does Efficacy Differ Between Compounded and Brand-Name Semaglutide?

Clinical efficacy is equivalent because both formulations contain semaglutide at the same concentration and purity standards. The STEP trials, which established Wegovy's weight loss outcomes—averaging 10–15% body weight reduction over 68 weeks—apply equally to compounded semaglutide from licensed pharmacies. Individual response depends on genetics, adherence, diet, exercise, and baseline metabolic health rather than whether the medication comes from a compounding pharmacy or a branded manufacturer.

PlexusDx offers the Precision Peptide Genetic Test, which identifies variants in your GLP1R, GIPR, FTO, and MC4R genes to predict your individual semaglutide response. This personalized insight helps optimize your starting dose and titration schedule, potentially improving your weight loss trajectory regardless of whether you choose compounded or brand-name therapy. Genetic testing can reveal whether you are a strong, moderate, or variable responder before committing to either option.

Reasons to Stay With Compounded Semaglutide or Switch to Wegovy

Stay with compounded semaglutide if cost is a barrier, you lack insurance, your insurance denies coverage, or you value dosing flexibility and rapid access to treatment. Compounded semaglutide from PlexusDx reaches you within days, requires no prior authorization, and costs predictably month to month. If you are satisfied with your weight loss results and side effect profile, switching to Wegovy introduces unnecessary complexity and expense.

Consider switching to Wegovy if your insurance provides robust coverage at a low copay, you prefer a branded product with extensive marketing support and patient programs, or you want access to Novo Nordisk's official weight loss community resources. Some patients also switch if they experience compounding pharmacy supply disruptions, though PlexusDx maintains consistent inventory across all 50 states. Switching itself is medically safe—your semaglutide dose can transition seamlessly between sources under provider guidance.

How to Safely Transition Between Semaglutide Sources

If you decide to switch from compounded semaglutide to Wegovy, consult your prescriber to confirm your current dose, then request a Wegovy prescription at an equivalent dose level. There is no medical washout period required; you can start your first Wegovy injection the week after your last compounded dose without loss of appetite suppression or increased side effects. Your provider should document your starting dose and titration history to ensure continuity of care.

Keep detailed records of your weight, hunger levels, and any side effects during the month after switching to identify whether the transition affects your response. Some patients report subtle differences in injection comfort or side effect timing between brands, though these typically resolve within one to two doses. If you experience unexpected changes, contact your prescriber immediately; they can adjust your dose or return you to compounded semaglutide without clinical concern.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is compounded semaglutide as safe as Wegovy?

Yes. PlexusDx sources compounded semaglutide from licensed 503A compounding pharmacies operating under FDA oversight and state pharmacy board regulations. Both compounded and brand-name semaglutide undergo quality testing and contain the same active ingredient, making safety profiles equivalent when dispensed by reputable compounders.

Will switching from compounded to Wegovy change my weight loss results?

No. Clinical efficacy is identical because both medications contain semaglutide at the same dose level. Your weight loss depends on your genetics, adherence, diet, and exercise—not the source of the medication. If your current results satisfy you, switching introduces unnecessary cost and logistical changes without clinical benefit.

How much money can I save by staying on PlexusDx compounded semaglutide?

PlexusDx compounded semaglutide starts at $149 per month with your dose able to increase while your price remains flat. Wegovy costs $900–$1,350 monthly without insurance, or $50–$500+ with insurance depending on your plan. Over one year, compounded semaglutide could save you $600–$13,000 compared to uninsured Wegovy, and often undercuts insured prices.

Can my insurance refuse to cover compounded semaglutide?

Insurance policies vary. Most insurers do not cover compounded medications, but PlexusDx compounded semaglutide is HSA/FSA eligible, and the flat $149/month cost avoids insurance bureaucracy entirely. If your insurance covers Wegovy at a low copay, that may be more economical; otherwise, direct payment through PlexusDx eliminates authorization delays.

How does PlexusDx Precision Peptide Genetic Testing help me choose between semaglutide sources?

The Precision Peptide Genetic Test ($99 add-on after your first month) identifies variants in GLP1R, GIPR, FTO, and MC4R genes that predict your individual semaglutide response strength. This helps optimize your dose and titration regardless of whether you use compounded or brand-name therapy, ensuring you maximize weight loss before considering a switch.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves